Tekla Capital Management LLC Organon & Co. Transaction History

Tekla Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $106,566 - $138,012	-3,717 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $1.44 Million - $1.8 Million	-50,452 Reduced 93.14%	3,717 $122,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $1.54 Million - $2.06 Million	54,169 New	54,169 $1.64 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.76B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.